玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

GNE-493

    
98%

GNE-493

源葉(MedMol)
S81768 一鍵復制產品信息
1033735-94-2
C17H20N6O2S
372.4447
HMS3244E04; GNE-493; HMS3244F03; UNII-0L843LS9YK; HMS3244E03;
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S81768-1mg 98% ¥240.00 10 - - -
S81768-5mg 98% ¥380.00 6 - - -
S81768-10mg 98% ¥610.00 6 - - -
S81768-25mg 98% ¥1070.00 5 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

GNE-493 is a potent, selective, and orally available dual pan-PI3-kinase/mTOR inhibitor with IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR.

產品描述: GNE-493 is a potent, selective, and orally available dual pan-PI3-kinase/mTOR inhibitor with IC50s of 3.4 nM, 12 nM, 16 nM, 16 nM and 32 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR.
靶點: PI3Kα:3.4 nM (IC50);PI3Kβ:12 nM (IC50);PI3Kδ:16 nM (IC50);PI3Kγ:16 nM (IC50);mTOR:30 nM (IC50);PI3K;?mTOR
體外研究: GNE-493 is a low molecular weight, potent dual inhibitor of pan-PI3 kinases and mTOR. GNE-493 displays approximately equipotent inhibition of Class I PI3K isoforms, is submitted for screening in a 142 kinase panel provided by Invitrogen’s SelectScreen service. Of these kinases, only three are subject to greater than 50% inhibition by GNE-493, and none are inhibited greater than 80% when tested at 1 μM. Subsequently measured IC50s demonstrated that GNE-493 is more than 100-fold selective for PI3Kα over these three unrelated kinases (Aurora A IC50>10 μM, MLK1 IC50=591 nM and SYK IC50=371 nM)
體內研究: To confirm and compare in vivo efficacy, GNE-493 is examined in the human MCF7.1 breast cancer xenograft model that harbors a PI3Kα activating mutation. Mice bearing xenografts are dosed orally once daily with 10 mg/kg of GNE-493 for 21 continuous days. Similar to observations made in the PC3 prostate cancer xenograft model, 10 mg/kg of GNE-493 results in 73% tumor growth inhibition at day 21 when compared to vehicle control animals. When achieving comparable levels of drug exposure, GNE-493 shows a similar suppression of the PI3K pathway and consequently, a similar efficacy profile against MCF7.1 breast tumors
參考文獻: 1. Sutherlin DP, et al. Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer. J Med Chem. 2010 Feb 11;53(3):1086-97.
溶解性: soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.685 ml 13.425 ml 26.85 ml
5 mM 0.537 ml 2.685 ml 5.37 ml
10 mM 0.268 ml 1.342 ml 2.685 ml
50 mM 0.054 ml 0.268 ml 0.537 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關產品

主站蜘蛛池模板: 西藏| 盐山县| 黔江区| 汉阴县| 防城港市| 西青区| 诸暨市| 苍梧县| 永吉县| 阜新| 汝南县| 饶阳县| 鹿泉市| 太仆寺旗| 雷州市| 眉山市| 明星| 筠连县| 松阳县| 阳泉市| 台湾省| 乐亭县| 雷山县| 木里| 衡水市| 象州县| 平陆县| 焦作市| 永丰县| 子长县| 兴隆县| 大足县| 乳源| 宁海县| 湖州市| 贡山| 东乡| 扶余县| 贵州省| 辉县市| 阳曲县|